These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3941017)

  • 101. [Chemo-sensitive differences of primary, metastatic and recurrent tumors of human colorectal cancer].
    Yamada K; Takao S; Maenohara S; Saihara T; Yoshinaga A; Haruyama K; Mitsuda K; Makizumi K; Ishizawa T; Shimazu H
    Nihon Shokakibyo Gakkai Zasshi; 1986 Nov; 83(11):2318-24. PubMed ID: 3820755
    [No Abstract]   [Full Text] [Related]  

  • 102. Tumor models for preclinical development of targeted agents.
    Teicher BA
    Prog Drug Res; 2005; 63():43-66. PubMed ID: 16265876
    [No Abstract]   [Full Text] [Related]  

  • 103. Chemosensitivity studies on human tumour cells from a pancreatic carcinoma xenograft.
    Smith IE
    J R Soc Med; 1979 Apr; 72(4):260-3. PubMed ID: 552510
    [No Abstract]   [Full Text] [Related]  

  • 104. Limitations and problems in clonogenic assays and chemosensitivity for cancer.
    Javadpour N
    Urology; 1983 Dec; 22(6):674-5. PubMed ID: 6649244
    [No Abstract]   [Full Text] [Related]  

  • 105. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 106. Pharmacologic assessment of regimen chemosensitivity in the soft-agar assay: effect of oxygen on human tumors.
    Fan D; Morgan LR; Schneider C; Blank H; Roy S; Wang YF; Fan S
    J Cancer Res Clin Oncol; 1985; 110(3):209-15. PubMed ID: 3841126
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Potentials and possible pitfalls of human stem cell analysis.
    Rosenblum ML; Dougherty DV; Reese C; Wilson CB
    Cancer Chemother Pharmacol; 1981; 6(3):227-35. PubMed ID: 7318145
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Tumor models for efficacy determination.
    Teicher BA
    Mol Cancer Ther; 2006 Oct; 5(10):2435-43. PubMed ID: 17041086
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Human tumor cloning: feasibility and clinical correlations.
    Von Hoff DD; Cowan J; Harris G; Reisdorf G
    Cancer Chemother Pharmacol; 1981; 6(3):265-71. PubMed ID: 7318147
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Individualized patient chemotherapy: use of a human tumor colony formation technique.
    Meyskens FL
    Front Radiat Ther Oncol; 1981; 16():55-61. PubMed ID: 7199500
    [No Abstract]   [Full Text] [Related]  

  • 111. Clones, dyes, nuclides, mouse kidneys, and ... virions: a new-clonogenic assay for tumor chemosensitivity.
    Weisenthal LM
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):9-12. PubMed ID: 3595687
    [No Abstract]   [Full Text] [Related]  

  • 112. Human tumor clonogenic assays. An overview.
    Sikic BI; Taber RL
    Cancer Chemother Pharmacol; 1981; 6(3):201-3. PubMed ID: 7318143
    [No Abstract]   [Full Text] [Related]  

  • 113. Potential of colony-forming cell assays in the evaluation of ovarian cancer.
    Aapro MS; Vermorken JB
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):357-8. PubMed ID: 3383939
    [No Abstract]   [Full Text] [Related]  

  • 114. Spontaneous alteration in growth rates of two human melanoma xenografts. Concurrent changes in chemosensitivity.
    Fodstad O; Rofstad EK; Tveit KM; Pihl A
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1175-8. PubMed ID: 6684563
    [No Abstract]   [Full Text] [Related]  

  • 115. [Symposium on treatment of cancer. Supplement 2. Differential sensitivities of long-term cultured cell lines derived from human haematopoietic malignancies to various anti-cancer drugs].
    Morikawa K; Note S
    Nihon Naika Gakkai Zasshi; 1984 Nov; 73(11):1625-7. PubMed ID: 6520521
    [No Abstract]   [Full Text] [Related]  

  • 116. Chemosensitivity of human neoplasms with in vitro clone formation. Experience at the University of Southern California - Los Angeles County Medical Center.
    Daniels JR; Daniels AM; Luck EE; Whitman B; Casagrande JT; Skinner DG
    Cancer Chemother Pharmacol; 1981; 6(3):245-51. PubMed ID: 6274537
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Future clinical perspectives. A concluding discussion.
    Eckhardt S
    Antibiot Chemother (1971); 1980; 28():147-52. PubMed ID: 7416727
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM
    Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
    [No Abstract]   [Full Text] [Related]  

  • 119. Interferon: an anti-cancer agent?
    Priestman TJ
    Cancer Treat Rev; 1979 Dec; 6(4):223-37. PubMed ID: 394839
    [No Abstract]   [Full Text] [Related]  

  • 120. [Pre-therapeutic testing of cytostatic agents for human tumors. In-vitro/in-vivo correlation (proceedings)].
    Schmidt-Matthiesen H; Bastert HG; Michel RT; Nord D; Gerner R; Sturm R
    Arch Gynakol; 1977 Jul; 224(1-4):356. PubMed ID: 579856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.